Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_assertion type Assertion NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_head.
- NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_assertion wasGeneratedBy ECO_0000203 NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_provenance.
- NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_assertion wasDerivedFrom befree-20140225 NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_provenance.
- NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_assertion SIO_000772 11287973 NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_provenance.
- NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_assertion evidence source_evidence_literature NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_provenance.
- NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_assertion description "[The BCR-ABL tyrosine kinase inhibitor STI571 is well tolerated and has substantial activity in the blast crises of CML and in Ph-positive ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160817.RAG6Ixk6I_CFjNLJSrZBjkzunKQ3W3NmsRWC4aDscfo8w130_provenance.